16714-929 : Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 16714-929
Labeler: Northstar Rxllc
Product Type: Human Prescription Drug
Drug Name:  Fosaprepitant
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA209965
Rev. Date: 


NDC Package Codes:

  • 16714-929-01: 1 VIAL IN 1 CARTON (16714‑929‑01) > 1 ML IN 1 VIAL

Active Ingredients:

  • Fosaprepitant Dimeglumine

Dosage Strength:

  • 150 mg/5mL

Pharmaceutical Classes:

  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 16714-120 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16714-248 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 0338-0008 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
  • 0591-4385 Fosaprepitant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 0781-3497 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc.
  • 16729-240 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
  • 25021-784 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 31722-165 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals, Inc.
  • 43598-671 Fosaprepitant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
  • 43598-859 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
  • 43598-948 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
  • 60505-6105 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-972 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 67457-888 Fosaprepitant 115 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 67457-889 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 68001-421 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-517 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-523 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68180-690 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Lupin Pharmaceuticals, Inc.
  • 69097-830 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Cipla USA Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16714-929 QR Code

< Prev: 16714-928Next: 16714-930 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.